OTC & Nutraceuticals North America

North America Insulin Resistance Supplements Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

North America Insulin Resistance Supplements Market Industry Trends and Forecast to 2034: Segmented by (Ingredient, Form, Distribution Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

North America · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $902.7 Mn Placeholder estimate
Estimate 2025 $973.1 Mn 51.2% of the global market
Projected 2034 $1.91 Bn 96.6% Adds $940.0 Mn over 9 forecast years
CAGR 2025–2034 7.8% Faster than 82% of 83 OTC & Nutraceuticals markets here
Key players 5
  • North America is 51.19% of the global market.
  • Among regions, the largest is North America (this report) at $973.1 Mn.
  • Fastest growing: APAC at 10.6% a year.
  • North America ranks 1st of 6 by size among regions.

Market size projection

North America

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$940.0 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Insulin Resistance Supplements Market market size by year, North America
YearMarket sizeChange that yearSince 2025
2024 (estimate) $902.7 Mn — —
2025 (base) $973.1 Mn +$70.4 Mn —
2026 (forecast) $1.05 Bn +$75.9 Mn +7.8%
2027 (forecast) $1.13 Bn +$81.8 Mn +16.2%
2028 (forecast) $1.22 Bn +$88.2 Mn +25.3%
2029 (forecast) $1.31 Bn +$95.1 Mn +35%
2030 (forecast) $1.42 Bn +$102.5 Mn +45.6%
2031 (forecast) $1.53 Bn +$110.5 Mn +56.9%
2032 (forecast) $1.65 Bn +$119.1 Mn +69.2%
2033 (forecast) $1.77 Bn +$128.4 Mn +82.4%
2034 (forecast) $1.91 Bn +$138.4 Mn +96.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

North America Insulin Resistance Supplements Market Analysis at a glance
Market size, 2025$973.1 Mn placeholder estimate
Forecast, 2034$1.91 Bn placeholder estimate
Growth (CAGR), 2025–20347.8% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsIngredient, form and distribution channel (see all)
Key playersThorne, NOW Foods, Nature’s Bounty, Pure Encapsulations, LLC, Wholesome Story (see all)
Active clinical trials163 in North AmericaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The North America Insulin Resistance Supplements Market Analysis Executive Summary

Insulin resistance supplements contain ingredients such as berberine, inositol, chromium and cinnamon that claim to support healthy blood sugar.

Key segments of the insulin Resistance Supplements market include ingredient (Berberine, Inositol and Chromium) and form (Capsules, Powders and Gummies).

Bar chart: North America Insulin Resistance Supplements market size, 2024–2034, placeholder estimates. $902.7 Mn in 2024, $973.1 Mn in 2025 and $1.91 Bn in 2034, 7.8% CAGR.
North America Insulin Resistance Supplements market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

North America Insulin Resistance Supplements Market Dynamics

Market Growth Drivers

Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the insulin Resistance Supplements market. Wider insurance coverage and more doctors trained in obesity care are adding to demand.

Opportunity

Oral formulations, combination therapies and use in heart, kidney and liver disease open new growth paths for the insulin Resistance Supplements market, especially in fast-growing emerging economies.

Market Restraints

High treatment prices, limited reimbursement, supply shortages and side effects that lead some patients to stop treatment hold back the insulin Resistance Supplements market. Long-term safety data and lifestyle support are still needed for many patients.

Competitive Landscape for Insulin Resistance Supplements Market in North America

The insulin Resistance Supplements market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Insulin Resistance Supplements Market in North America

Insulin Resistance Supplements in North America: rules and research

In the countries we cover here, medicines are approved by Health Canada (Canada)⁠[1] and FDA (US)⁠[2]. In the countries we cover here, supplement rules come from Health Canada (Canada)⁠[3] and FDA (US)⁠[4]. ClinicalTrials.gov lists 163 studies on Insulin Resistance Supplements that are recruiting, active or about to start in North America.⁠[5]

[1] Health Canada. Checked 14 Nov 2026.

[2] US Food and Drug Administration. Checked 14 Nov 2026.

[3] Health Canada. Checked 14 Nov 2026.

[4] US Food and Drug Administration. Checked 14 Nov 2026.

[5] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Food and supplement rules, labelling and health-claim regulations govern insulin Resistance Supplements products. Authorities such as the US FDA, EFSA and national food safety bodies set what can be sold and claimed in North America.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Insulin Resistance Supplements right now, from free public sources.

Clinical trials

163 active trials in US and Canada

Recruiting, about to start, or running now. Counted across the 2 countries we report on in North America.

Top trial sponsors (worldwide)

  1. Hangzhou Sciwind Biosciences Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Signos 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, WHO Global Health Observatory. Fetched 21 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Insulin Resistance Supplements in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the Insulin Resistance Supplements market in North America?
Placeholder estimate: about $973.1 Mn in 2025, rising to about $1.91 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Insulin Resistance Supplements market in North America growing?
Placeholder estimate: about 7.8% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Insulin Resistance Supplements market report cover?
The report splits the market by ingredient (Berberine, Inositol, Chromium, Cinnamon Extract and more), form (Capsules, Powders, Gummies) and distribution channel (Supermarkets and Hypermarkets, Pharmacies and Drug Stores, Online Retail, Specialty Stores).
Who are the key players in the Insulin Resistance Supplements market?
Key players include Thorne, NOW Foods, Nature’s Bounty, Pure Encapsulations, LLC and Wholesome Story.
What is driving the Insulin Resistance Supplements market?
Rising rates of obesity and type 2 diabetes, strong clinical results for new weight-loss medicines and growing acceptance of obesity as a chronic disease are driving the insulin Resistance Supplements market.
How many clinical trials on Insulin Resistance Supplements are running in North America?
163 studies are recruiting, active or about to start in North America, counted across the 2 countries we report on there, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in North America. Retrieved 12 Nov 2026.
How much research is published on Insulin Resistance Supplements?
PubMed lists 2,843 papers on Insulin Resistance Supplements added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related OTC & Nutraceuticals reports in North America

See all

Related on diabetes and nutrition

See the topic